Cover Image

SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome

Saved in:

Bibliographic Details
Main Authors:	Vito Fiore (Author), Andrea De Vito (Author), Giordano Madeddu (Author), Sergio Babudieri (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel
by: Vito Fiore, et al.
Published: (2022)

HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project
by: Andrea De Vito, et al.
Published: (2023)

Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study
by: Paradiso, Angelo Virgilio, et al.
Published: (2020)

Resistance in <i>Pseudomonas aeruginosa</i>: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
by: Federico Giovagnorio, et al.
Published: (2023)

An Overview of the Temporal Shedding of SARS-CoV-2 RNA in Clinical Specimens
by: Khrystyna Zhurakivska, et al.
Published: (2020)

Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections
by: Swee Li Ng BPharm (Hons), et al.
Published: (2021)

Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections
by: Swee Li Ng BPharm (Hons), et al.
Published: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Competitive sport after SARS-CoV-2 infection in children
by: Giulia Cafiero, et al.
Published: (2021)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
by: Massimiliano Di Filippo, et al.
Published: (2022)

Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection
by: Mario Dioguardi, et al.
Published: (2021)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023)

T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022)

The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects
by: Gianluca Cappelleri, et al.
Published: (2021)

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People
by: Umar Saeed, et al.
Published: (2021)

Vaccine safety - is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023)

Vitiligo Repigmentation After SARS-CoV-2 Vaccine
by: Roberto Bustos-Macaya, et al.
Published: (2023)

Alopecia areata after SARS-CoV-2 vaccination
by: Margaret E. Scollan, MSc, et al.
Published: (2022)

Pregnancy and SARS - CoV - 2 vaccination: Unraveling the myths
by: Anita Yadav, et al.
Published: (2021)

SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022)

SARS-CoV-2 reinfection and implications for vaccine development
by: Firzan Nainu, et al.
Published: (2020)

SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021)

SARS-CoV-2 Vaccination for Children-An Open Issue
by: Désirée Caselli, et al.
Published: (2021)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

Intussusception and SARS-CoV-2 infection
by: Israel Mercado-Martínez, et al.
Published: (2021)

Rare lymphomatoid reactions following SARS-CoV-2 vaccination
by: Tessa LeWitt, BS, et al.
Published: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
by: Hiroki Morimoto, et al.
Published: (2022)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
by: Michael Levin, et al.
Published: (2022)

VITT with inactivated SARS-CoV-2 vaccine - index case
by: Kanta Devi, et al.
Published: (2022)

SARS-CoV-2 vaccination in the context of original antigenic sin
by: Marek Petráš, et al.
Published: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
by: Rajat Mudgal, et al.
Published: (2020)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)